DEOXYCHOLIC ACID

DEOXYCHOLIC ACID was reported 2334 times

DEOXYCHOLIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE MOVEMENT IMPAIRMENT 1 0.1667
1 VIITH NERVE INJURY 10 0.1235
2 ADMINISTRATION SITE SCAB 3 0.1154
3 APPLICATION SITE ALOPECIA 6 0.1091
4 INJECTION SITE ALOPECIA 4 0.0909
5 ADMINISTRATION SITE INDURATION 8 0.0889
6 INJECTION SITE DEFORMATION 6 0.0674
7 VTH NERVE INJURY 3 0.0612
8 SKIN PROCEDURAL COMPLICATION 1 0.0588
9 FACIAL ASYMMETRY 54 0.0566
10 CUTANEOUS CONTOUR DEFORMITY 1 0.0526
11 TRIGEMINAL NERVE PARESIS 1 0.0526
12 SKIN LAXITY 23 0.0525
13 APPLICATION SITE PLAQUE 1 0.0435
14 FACIAL PARESIS 130 0.0367
15 INJECTION SITE HYPOAESTHESIA 52 0.0363
16 ADMINISTRATION SITE ABSCESS 1 0.0294
17 FAT TISSUE INCREASED 41 0.0283
18 GASTRIC HYPERTONIA 1 0.0270
19 INJECTION SITE PALLOR 8 0.0253
20 ADMINISTRATION SITE NECROSIS 1 0.0250
21 EXCESSIVE SKIN 7 0.0248
22 INJECTION SITE ULCER 22 0.0233
23 SKIN INDENTATION 11 0.0233
24 PERIORBITAL FAT ATROPHY 1 0.0233
25 NECROSIS OF ARTERY 1 0.0222
26 TRIGEMINAL PALSY 1 0.0217
27 CRANIAL NERVE INJURY 2 0.0206
28 PELVIC MISALIGNMENT 1 0.0196
29 INDURATION 34 0.0191
30 INJECTION SITE JOINT SWELLING 1 0.0179
31 INJECTION SITE NERVE DAMAGE 4 0.0167
32 ADMINISTRATION SITE DISCOLOURATION 2 0.0160
33 INJECTION SITE HYPERAESTHESIA 3 0.0155
34 SOFT TISSUE ATROPHY 1 0.0141
35 INJECTION SITE ISCHAEMIA 1 0.0139
36 INJECTION SITE NECROSIS 28 0.0137
37 ORAL MUCOSA HAEMATOMA 1 0.0137
38 INJECTION SITE HYPERTROPHY 4 0.0123
39 ADMINISTRATION SITE WARMTH 1 0.0122
40 INJECTION SITE SCAB 11 0.0114
41 MANDIBULAR MASS 1 0.0114
42 NECK DEFORMITY 5 0.0113
43 INJECTION SITE NODULE 123 0.0112
44 TONGUE THRUST 1 0.0111
45 PROGNATHISM 1 0.0106
46 NIPPLE EXUDATE BLOODY 2 0.0106
47 KOEBNER PHENOMENON 1 0.0104
48 NERVE INJURY 115 0.0103
49 PROPIONIBACTERIUM INFECTION 1 0.0094
50 JAW CLICKING 2 0.0094
51 RENAL PAPILLARY NECROSIS 2 0.0093
52 TISSUE INJURY 4 0.0092
53 FACIAL NERVE DISORDER 4 0.0090
54 VASCULAR OCCLUSION 19 0.0090
55 POST INFLAMMATORY PIGMENTATION CHANGE 4 0.0088
56 MALPOSITIONED TEETH 1 0.0087
57 INJECTION SITE FIBROSIS 1 0.0085
58 INJECTION SITE GRANULOMA 2 0.0084
59 VASCULAR INJURY 12 0.0083
60 CORONARY ARTERY PERFORATION 1 0.0081
61 COUGH DECREASED 1 0.0075
62 INJECTION SITE EXFOLIATION 5 0.0075
63 FACIAL WASTING 2 0.0074
64 CUTIS LAXA 2 0.0074
65 APPLICATION SITE NODULE 1 0.0073
66 ERYTHEMA INDURATUM 1 0.0070
67 INJECTION SITE DERMATITIS 1 0.0069
68 INJECTION SITE CYST 2 0.0068
69 PARAESTHESIA EAR 1 0.0068
70 DERMATOCHALASIS 1 0.0068
71 PATIENT DISSATISFACTION WITH TREATMENT 13 0.0067
72 ARTERIAL INJURY 5 0.0067
73 INJECTION SITE SCAR 19 0.0067
74 INJECTION SITE INDURATION 86 0.0066
75 FACIAL OPERATION 1 0.0062
76 ADMINISTRATION SITE SWELLING 2 0.0062
77 APPLICATION SITE INDURATION 1 0.0059
78 INJECTION SITE PARAESTHESIA 9 0.0059
79 SPEECH SOUND DISORDER 1 0.0058
80 INJECTION SITE EROSION 2 0.0057
81 MULTIFOCAL MOTOR NEUROPATHY 1 0.0057
82 THYROID PAIN 1 0.0056
83 SKIN WRINKLING 15 0.0055
84 ADMINISTRATION SITE DISCOMFORT 1 0.0053
85 APPLICATION SITE INJURY 1 0.0053
86 INJECTION SITE PUSTULE 2 0.0052
87 INJECTION SITE OEDEMA 9 0.0052
88 FAT TISSUE DECREASED 2 0.0051
89 ADMINISTRATION RELATED REACTION 1 0.0051
90 LEUKODERMA 1 0.0050
91 LIPOHYPERTROPHY 3 0.0048
92 PELVIC FLOOR DYSFUNCTION 1 0.0047
93 PRODUCT ADVERTISING ISSUE 1 0.0047
94 HYPERPLASIA 4 0.0044
95 NEURALGIC AMYOTROPHY 1 0.0044
96 SOFT TISSUE MASS 2 0.0043
97 ORAL CONTUSION 1 0.0043
98 FAT REDISTRIBUTION 1 0.0043
99 ORAL PUSTULE 1 0.0043
100 APPLICATION SITE HYPOAESTHESIA 1 0.0043
101 LIPOATROPHY 4 0.0042
102 SKIN TEXTURE ABNORMAL 4 0.0042
103 INJECTION SITE SWELLING 305 0.0040
104 SKIN INDURATION 8 0.0039
105 BODY FAT DISORDER 2 0.0037
106 LIP DISORDER 7 0.0037
107 SOFT TISSUE DISORDER 4 0.0036
108 NODULE 46 0.0035
109 FACIAL PARALYSIS 30 0.0035
110 ADMINISTRATION SITE ERYTHEMA 1 0.0035
111 INJECTION SITE INFLAMMATION 17 0.0034
112 PREMATURE AGEING 1 0.0034
113 FROSTBITE 1 0.0033
114 HEAD DEFORMITY 1 0.0033
115 MALABSORPTION FROM INJECTION SITE 1 0.0032
116 TENDERNESS 33 0.0032
117 SOFT TISSUE INFLAMMATION 1 0.0030
118 CYST RUPTURE 2 0.0029
119 MUSCLE HYPERTROPHY 1 0.0028
120 INJECTION SITE MASS 104 0.0028
121 SWELLING 262 0.0028
122 SKIN TIGHTNESS 13 0.0028
123 SHOCK SYMPTOM 1 0.0027
124 SKIN NECROSIS 14 0.0027
125 INJECTION SITE CELLULITIS 5 0.0027
126 LID SULCUS DEEPENED 1 0.0027
127 POLYCYSTIC OVARIAN SYNDROME 1 0.0026
128 CAPILLARY DISORDER 1 0.0026
129 NEUTROPHILIC DERMATOSIS 1 0.0025
130 INJECTION SITE DISCOLOURATION 31 0.0025
131 GRANULOMA SKIN 2 0.0024
132 INJECTION SITE ATROPHY 4 0.0024
133 SKIN WOUND 4 0.0024
134 TONGUE MOVEMENT DISTURBANCE 2 0.0023
135 LIP PRURITUS 2 0.0023
136 INJECTION SITE INDENTATION 5 0.0023
137 REFLUX LARYNGITIS 1 0.0023
138 HYPOAESTHESIA ORAL 34 0.0023
139 NUCHAL RIGIDITY 2 0.0022
140 CHLOASMA 1 0.0022
141 INJECTION SITE INFECTION 7 0.0021
142 CRANIAL NERVE PARALYSIS 1 0.0021
143 OPEN FRACTURE 1 0.0021
144 APPLICATION SITE BRUISE 2 0.0021
145 INJECTION SITE ABSCESS 5 0.0020
146 INJECTION SITE DISCOMFORT 21 0.0020
147 ADHESION 3 0.0020
148 ACCIDENT AT HOME 1 0.0019
149 KELOID SCAR 1 0.0019
150 TRI-IODOTHYRONINE DECREASED 1 0.0019
151 DEVICE USE CONFUSION 1 0.0019
152 FACIAL PAIN 17 0.0019
153 TEMPOROMANDIBULAR JOINT SYNDROME 5 0.0019
154 HYPERTROPHY 1 0.0018
155 POST PROCEDURAL SWELLING 2 0.0018
156 INJECTION SITE VESICLES 11 0.0018
157 LIFE SUPPORT 1 0.0018
158 COLLAGEN DISORDER 1 0.0017
159 CHEMICAL BURN 2 0.0017
160 ALOPECIA AREATA 3 0.0017
161 HYPOAESTHESIA EYE 1 0.0017
162 PUSTULE 4 0.0017
163 LYMPHATIC DISORDER 1 0.0017
164 FAT NECROSIS 1 0.0016
165 ALLERGY TO METALS 1 0.0016
166 SEROMA 2 0.0016
167 SPIDER VEIN 1 0.0016
168 HYPOTRICHOSIS 1 0.0016
169 IATROGENIC INJURY 2 0.0016
170 NASAL SEPTUM PERFORATION 1 0.0015
171 PAROTID GLAND ENLARGEMENT 1 0.0015
172 COUNTERFEIT PRODUCT ADMINISTERED 2 0.0015
173 GINGIVAL DISCOMFORT 1 0.0015
174 ABSCESS NECK 1 0.0015
175 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 27 0.0015
176 CLUSTER HEADACHE 2 0.0015
177 INJECTION SITE MACULE 1 0.0015
178 SOFT TISSUE NECROSIS 1 0.0015
179 RADIOISOTOPE SCAN ABNORMAL 1 0.0014
180 FACIAL DISCOMFORT 1 0.0014
181 APPLICATION SITE SWELLING 7 0.0014
182 MYCOBACTERIUM ABSCESSUS INFECTION 1 0.0014
183 CALCINOSIS 3 0.0013
184 IMPETIGO 2 0.0013
185 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
186 TENDON DISCOMFORT 1 0.0013
187 BLOOD KETONE BODY INCREASED 1 0.0013
188 SKIN HYPERPIGMENTATION 11 0.0013
189 INJECTION SITE HYPERSENSITIVITY 4 0.0013
190 MAMMOPLASTY 1 0.0013
191 OCCUPATIONAL EXPOSURE TO PRODUCT 8 0.0012
192 EXCESSIVE GRANULATION TISSUE 1 0.0012
193 PAIN IN JAW 35 0.0012
194 CHEMICAL INJURY 1 0.0012
195 DENTAL DISCOMFORT 1 0.0012
196 LIPOMA 3 0.0012
197 SPINAL CORD INJURY 2 0.0011
198 MASS 16 0.0011
199 SKIN HYPOPIGMENTATION 2 0.0011
200 PARAESTHESIA ORAL 16 0.0011
201 INJECTION SITE DRYNESS 1 0.0011
202 VASOSPASM 1 0.0011
203 PHARYNGEAL HYPOAESTHESIA 1 0.0011
204 VENOUS INJURY 1 0.0011
205 DEFORMITY 10 0.0011
206 SKIN HYPERTROPHY 3 0.0011
207 THERAPEUTIC RESPONSE INCREASED 1 0.0011
208 NECK MASS 3 0.0011
209 FACE INJURY 4 0.0011
210 SCAB 12 0.0011
211 PARALYSIS 15 0.0010
212 LIP PAIN 3 0.0010
213 ACTINOMYCOSIS 1 0.0010
214 NECK INJURY 3 0.0010
215 WRONG DRUG ADMINISTERED 9 0.0010
216 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
217 REDUCED FACIAL EXPRESSION 1 0.0010
218 BENIGN BREAST NEOPLASM 1 0.0010
219 MASTICATION DISORDER 3 0.0010
220 LIVEDO RETICULARIS 2 0.0010
221 INJECTION SITE BRUISING 76 0.0010
222 PHARYNGEAL ERYTHEMA 2 0.0009
223 SKIN SWELLING 8 0.0009
224 PALLOR 25 0.0009
225 FEAR OF DEATH 2 0.0009
226 CONTUSION 85 0.0009
227 INJECTION SITE PAPULE 4 0.0009
228 SKIN ATROPHY 5 0.0009
229 MUCOSAL HAEMORRHAGE 1 0.0009
230 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
231 LIP ULCERATION 1 0.0009
232 THERMAL BURN 6 0.0008
233 ODYNOPHAGIA 5 0.0008
234 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 1 0.0008
235 ORAL MUCOSA EROSION 1 0.0008
236 VICTIM OF CRIME 1 0.0008
237 ALLERGY TO CHEMICALS 1 0.0008
238 SUBCUTANEOUS HAEMATOMA 1 0.0008
239 SWELLING FACE 51 0.0008
240 INJECTION SITE WARMTH 16 0.0008
241 TRISMUS 4 0.0008
242 WOUND SECRETION 3 0.0008
243 LIP INJURY 1 0.0008
244 LIP EXFOLIATION 1 0.0008
245 SKIN MASS 5 0.0007
246 WRONG PRODUCT ADMINISTERED 5 0.0007
247 OFF LABEL USE OF DEVICE 1 0.0007
248 TONGUE DRY 1 0.0007
249 SKIN ULCER 19 0.0007
250 HYPOAESTHESIA 110 0.0007
251 SKIN DEPIGMENTATION 1 0.0007
252 EFFUSION 1 0.0007
253 ABSCESS ORAL 1 0.0007
254 CORNEAL ABRASION 1 0.0007
255 NASAL DISCHARGE DISCOLOURATION 1 0.0007
256 THYROID NEOPLASM 2 0.0007
257 INCISIONAL HERNIA 1 0.0007
258 THERAPEUTIC PROCEDURE 1 0.0007
259 SCAR 12 0.0007
260 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
261 TENSION HEADACHE 3 0.0007
262 DARK CIRCLES UNDER EYES 1 0.0007
263 LYMPHADENOPATHY 24 0.0007
264 DRUG ADMINISTERED AT INAPPROPRIATE SITE 7 0.0007
265 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
266 SKIN DISCOLOURATION 29 0.0006
267 PHARYNGEAL PARAESTHESIA 1 0.0006
268 INJECTION SITE PAIN 191 0.0006
269 SENSORY LOSS 5 0.0006
270 INJECTION SITE RASH 19 0.0006
271 MUSCLE TIGHTNESS 10 0.0006
272 MUSCLE DISORDER 5 0.0006
273 OROPHARYNGEAL BLISTERING 1 0.0006
274 SPLENIC RUPTURE 1 0.0006
275 TOOTHACHE 11 0.0006
276 SKIN INJURY 2 0.0006
277 GASTRIC DILATATION 1 0.0006
278 VEIN RUPTURE 1 0.0006
279 TONSILLAR HYPERTROPHY 1 0.0006
280 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
281 EAR DISCOMFORT 6 0.0006
282 CERVICAL SPINAL STENOSIS 1 0.0006
283 PRODUCT COUNTERFEIT 1 0.0006
284 SENSITIVITY OF TEETH 1 0.0006
285 GRANULOMA 2 0.0006
286 NECK PAIN 32 0.0006
287 BURNS SECOND DEGREE 1 0.0006
288 PAPULE 4 0.0006
289 BREAST CYST 1 0.0006
290 PYODERMA GANGRENOSUM 2 0.0006
291 ABORTION INCOMPLETE 1 0.0005
292 ANGIOPATHY 3 0.0005
293 TUNNEL VISION 1 0.0005
294 PERIORBITAL SWELLING 3 0.0005
295 MYELOPATHY 1 0.0005
296 GINGIVAL RECESSION 1 0.0005
297 MOUTH SWELLING 3 0.0005
298 INJECTION SITE ERYTHEMA 64 0.0005
299 SKIN WARM 3 0.0005
300 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
301 HYPERAEMIA 1 0.0005
302 ANORECTAL DISORDER 1 0.0005
303 LIBIDO INCREASED 1 0.0005
304 EYELID PAIN 1 0.0005
305 LIP SWELLING 16 0.0005
306 SENSATION OF FOREIGN BODY 4 0.0005
307 OPTIC NEUROPATHY 1 0.0005
308 EXPOSED BONE IN JAW 1 0.0005
309 CHAPPED LIPS 2 0.0005
310 LOCAL SWELLING 8 0.0005
311 SKIN DISORDER 15 0.0004
312 SENSORY DISTURBANCE 7 0.0004
313 ORAL PRURITUS 1 0.0004
314 EYELID DISORDER 1 0.0004
315 LOCALISED OEDEMA 2 0.0004
316 LICHEN PLANUS 1 0.0004
317 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
318 PANIC REACTION 3 0.0004
319 PULSE ABNORMAL 1 0.0004
320 SELF ESTEEM DECREASED 1 0.0004
321 EAR PAIN 8 0.0004
322 DYSPHAGIA 39 0.0004
323 ORAL DISORDER 3 0.0004
324 INFLAMMATION 21 0.0004
325 SUFFOCATION FEELING 1 0.0004
326 VASODILATATION 1 0.0004
327 VULVOVAGINAL PRURITUS 2 0.0004
328 CHEMICAL BURN OF SKIN 1 0.0004
329 INJECTION SITE IRRITATION 5 0.0004
330 EXPIRED PRODUCT ADMINISTERED 13 0.0004
331 MUSCLE TWITCHING 9 0.0004
332 PRODUCT COLOUR ISSUE 2 0.0004
333 ANAESTHETIC COMPLICATION 1 0.0004
334 INJECTION SITE DISCHARGE 2 0.0004
335 MIGRAINE WITH AURA 1 0.0004
336 LIP BLISTER 1 0.0004
337 HYPERAESTHESIA 3 0.0004
338 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
339 CHOKING SENSATION 2 0.0004
340 INJECTION SITE INJURY 2 0.0004
341 NECROSIS 2 0.0004
342 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
343 OESOPHAGEAL STENOSIS 1 0.0004
344 VOMITING PROJECTILE 1 0.0003
345 TOOTH DISCOLOURATION 1 0.0003
346 ACNE CYSTIC 1 0.0003
347 OFF LABEL USE 287 0.0003
348 FIBROSIS 1 0.0003
349 CHOLANGITIS 2 0.0003
350 SWOLLEN TONGUE 10 0.0003
351 BLOOD BLISTER 1 0.0003
352 CUSHINGOID 1 0.0003
353 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
354 SKIN EROSION 1 0.0003
355 SPEECH DISORDER 16 0.0003
356 PRODUCT PREPARATION ISSUE 2 0.0003
357 ASPERGILLUS INFECTION 2 0.0003
358 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
359 HYPOTONIA 3 0.0003
360 BK VIRUS INFECTION 1 0.0003
361 B-CELL LYMPHOMA 1 0.0003
362 ECCHYMOSIS 2 0.0003
363 WOUND COMPLICATION 1 0.0003
364 DROOLING 2 0.0003
365 ENCEPHALITIS 2 0.0003
366 HAIR GROWTH ABNORMAL 2 0.0003
367 HYPOPNOEA 1 0.0003
368 PRESYNCOPE 7 0.0003
369 ORAL DISCOMFORT 4 0.0003
370 APHONIA 4 0.0003
371 EAR PRURITUS 1 0.0003
372 DEVICE PLACEMENT ISSUE 1 0.0003
373 OEDEMA 15 0.0003
374 TONGUE DISORDER 2 0.0003
375 BIPOLAR DISORDER 3 0.0003
376 INJECTION SITE HAEMATOMA 4 0.0003
377 PARADOXICAL DRUG REACTION 1 0.0003
378 HYPERACUSIS 1 0.0003
379 DISCOMFORT 16 0.0003
380 PROCEDURAL COMPLICATION 2 0.0003
381 OESOPHAGEAL DISORDER 1 0.0003
382 VIRAL LOAD INCREASED 1 0.0003
383 PULMONARY HAEMORRHAGE 2 0.0003
384 ABSCESS 4 0.0003
385 OBSTRUCTION 1 0.0003
386 FOREIGN BODY 1 0.0002
387 BLISTER 14 0.0002
388 ORGAN FAILURE 1 0.0002
389 DRUG INEFFECTIVE 327 0.0002
390 PRODUCT ADMINISTRATION ERROR 5 0.0002
391 GOITRE 1 0.0002
392 CONDITION AGGRAVATED 74 0.0002
393 PRODUCT PREPARATION ERROR 5 0.0002
394 SOCIAL PROBLEM 1 0.0002
395 MUSCLE INJURY 2 0.0002
396 DERMATITIS 5 0.0002
397 MUSCLE ATROPHY 3 0.0002
398 TONGUE DISCOMFORT 1 0.0002
399 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
400 PSEUDOMONAS INFECTION 2 0.0002
401 HAEMATOMA 6 0.0002
402 HORDEOLUM 1 0.0002
403 TONGUE DISCOLOURATION 1 0.0002
404 DYSPHEMIA 1 0.0002
405 LIGAMENT RUPTURE 1 0.0002
406 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
407 INJECTION SITE PRURITUS 15 0.0002
408 LIP DRY 2 0.0002
409 ALOPECIA 43 0.0002
410 ISCHAEMIA 1 0.0002
411 INTERCEPTED MEDICATION ERROR 1 0.0002
412 EYE SWELLING 8 0.0002
413 THERAPEUTIC RESPONSE DECREASED 13 0.0002
414 ERYTHEMA 44 0.0002
415 MUSCULOSKELETAL DISORDER 4 0.0002
416 RASH ERYTHEMATOUS 10 0.0002
417 LIMB OPERATION 1 0.0002
418 GUILLAIN-BARRE SYNDROME 1 0.0002
419 AUTOIMMUNE DISORDER 2 0.0002
420 PHARYNGEAL SWELLING 2 0.0002
421 INJECTION SITE URTICARIA 5 0.0002
422 APPLICATION SITE BURN 1 0.0002
423 DYSKINESIA 8 0.0002
424 PERIPHERAL VASCULAR DISORDER 1 0.0002
425 PERIORBITAL OEDEMA 1 0.0002
426 TONSILLITIS 1 0.0002
427 WEIGHT FLUCTUATION 2 0.0002
428 ULCER 3 0.0002
429 DYSARTHRIA 7 0.0002
430 PAIN OF SKIN 5 0.0002
431 BURNING SENSATION 13 0.0002
432 CHEILITIS 1 0.0002
433 SKIN LACERATION 2 0.0002
434 OROPHARYNGEAL PAIN 17 0.0002
435 JAW DISORDER 1 0.0002
436 SKIN LESION 5 0.0002
437 ASTHENOPIA 1 0.0002
438 STREPTOCOCCAL INFECTION 1 0.0002
439 WOUND 5 0.0002
440 SKIN INFECTION 2 0.0002
441 EYE INFECTION 2 0.0002
442 INTERNAL HAEMORRHAGE 2 0.0002
443 PRODUCT LABEL CONFUSION 1 0.0002
444 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
445 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
446 NEURALGIA 4 0.0002
447 PIGMENTATION DISORDER 1 0.0002
448 GENERALISED OEDEMA 2 0.0002
449 HAIR COLOUR CHANGES 2 0.0002
450 SWELLING OF EYELID 1 0.0002
451 APPLICATION SITE VESICLES 1 0.0002
452 HERPES SIMPLEX 1 0.0002
453 SKIN BURNING SENSATION 11 0.0002
454 SKIN IRRITATION 7 0.0002
455 BEDRIDDEN 2 0.0002
456 ADVERSE REACTION 2 0.0002
457 PARAESTHESIA 23 0.0001
458 INJECTION SITE REACTION 10 0.0001
459 LYMPHOEDEMA 1 0.0001
460 SKIN EXFOLIATION 12 0.0001
461 APPLICATION SITE REACTION 1 0.0001
462 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
463 SEASONAL ALLERGY 2 0.0001
464 FEAR OF INJECTION 1 0.0001
465 GRAFT VERSUS HOST DISEASE 1 0.0001
466 DERMATITIS BULLOUS 1 0.0001
467 RASH PUSTULAR 1 0.0001
468 DYSPHONIA 8 0.0001
469 APPLICATION SITE PAIN 3 0.0001
470 SENSITIVE SKIN 1 0.0001
471 ORAL PAIN 3 0.0001
472 PAIN 82 0.0001
473 VISION BLURRED 18 0.0001
474 BOWEL MOVEMENT IRREGULARITY 1 0.0001
475 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
476 PHARYNGEAL OEDEMA 2 0.0001
477 ADVERSE DRUG REACTION 11 0.0001
478 ABNORMAL FAECES 1 0.0001
479 EMBOLISM 1 0.0001
480 EOSINOPHIL COUNT INCREASED 1 0.0001
481 HAEMODIALYSIS 1 0.0001
482 PRODUCT CONTAINER ISSUE 1 0.0001
483 MUSCULOSKELETAL DISCOMFORT 2 0.0001
484 MUSCLE STRAIN 1 0.0001
485 PYELONEPHRITIS 1 0.0001
486 MIGRAINE 11 0.0001
487 MUSCULAR WEAKNESS 13 0.0001
488 JOINT STIFFNESS 3 0.0001
489 MUSCULOSKELETAL STIFFNESS 10 0.0001
490 GROIN PAIN 1 0.0001
491 SPINAL OSTEOARTHRITIS 1 0.0001
492 COLD SWEAT 2 0.0001
493 URTICARIA 19 0.0001
494 PRODUCT COMMUNICATION ISSUE 1 0.0001
495 HEAD DISCOMFORT 2 0.0001
496 THROAT TIGHTNESS 3 0.0001
497 OROPHARYNGEAL DISCOMFORT 1 0.0001
498 RETINAL DETACHMENT 1 0.0001
499 ADVERSE EVENT 10 0.0001
500 NERVE COMPRESSION 1 0.0001
501 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
502 PHOTOPHOBIA 2 0.0001
503 LACERATION 1 0.0001
504 ARTERIOSCLEROSIS 1 0.0001
505 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
506 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
507 POST PROCEDURAL COMPLICATION 2 0.0001
508 VITREOUS FLOATERS 1 0.0001
509 SALIVARY HYPERSECRETION 1 0.0001
510 PREGNANCY 2 0.0001
511 BRAIN INJURY 1 0.0001
512 APHASIA 3 0.0001
513 CELLULITIS 5 0.0001
514 PRODUCT PHYSICAL ISSUE 2 0.0001
515 DRY THROAT 1 0.0001
516 NERVOUS SYSTEM DISORDER 3 0.0001
517 FOLLICULITIS 1 0.0001
518 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
519 JOINT DISLOCATION 1 0.0001
520 WEIGHT INCREASED 21 0.0001
521 PHARYNGITIS STREPTOCOCCAL 1 0.0001
522 ACNE 7 0.0001
523 HYPERSENSITIVITY 17 0.0001
524 IMPAIRED HEALING 3 0.0001
525 TOOTH FRACTURE 1 0.0001
526 GAIT INABILITY 3 0.0001
527 RASH 39 0.0001
528 GLOSSODYNIA 2 0.0001
529 RASH PAPULAR 2 0.0001
530 IMPAIRED DRIVING ABILITY 1 0.0001
531 NEOPLASM 1 0.0001
532 EYELID OEDEMA 1 0.0001
533 POST PROCEDURAL HAEMORRHAGE 1 0.0001
534 CHILLS 10 0.0001
535 ACCIDENT 1 0.0001
536 THYROID CANCER 1 0.0001
537 CRYING 3 0.0001
538 VERTIGO 5 0.0001
539 FEELING HOT 5 0.0001
540 INJECTION SITE EXTRAVASATION 1 0.0001
541 AGEUSIA 2 0.0001
542 PEMPHIGUS 1 0.0001
543 DERMATITIS ALLERGIC 1 0.0001
544 AMNESIA 5 0.0001
545 IMMUNE SYSTEM DISORDER 1 0.0001
546 INJECTION SITE HAEMORRHAGE 6 0.0001
547 EMOTIONAL DISTRESS 9 0.0001
548 MOOD ALTERED 2 0.0001
549 PERIPHERAL COLDNESS 1 0.0001
550 PROCEDURAL PAIN 2 0.0001
551 FEELING COLD 2 0.0001
552 BLINDNESS UNILATERAL 1 0.0001
553 EYE PAIN 4 0.0001
554 DIALYSIS 1 0.0001
555 IMPAIRED QUALITY OF LIFE 1 0.0001
556 EYE IRRITATION 4 0.0001
557 ANOSMIA 1 0.0001
558 HYPERTHYROIDISM 1 0.0001
559 HYPOKINESIA 1 0.0001
560 DYSSTASIA 2 0.0001
561 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
562 DYSGEUSIA 5 0.0001
563 THROAT IRRITATION 3 0.0001
564 BONE LOSS 1 0.0001
565 TINNITUS 3 0.0001
566 CEREBROVASCULAR ACCIDENT 11 0.0001
567 THYROID DISORDER 1 0.0001
568 EMOTIONAL DISORDER 2 0.0001
569 MUSCULOSKELETAL CHEST PAIN 1 0.0001
570 WEIGHT DECREASED 18 0.0001
571 ACUTE MYELOID LEUKAEMIA 1 0.0001
572 CYANOSIS 1 0.0001
573 PREMATURE DELIVERY 1 0.0001
574 FEELING ABNORMAL 15 0.0001
575 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
576 INFLUENZA LIKE ILLNESS 5 0.0001
577 PHOTOSENSITIVITY REACTION 1 0.0001
578 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
579 FACE OEDEMA 1 0.0001
580 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
581 FLUID RETENTION 3 0.0001
582 HAEMATURIA 2 0.0001
583 RASH MACULAR 2 0.0001
584 HYPOXIA 2 0.0001
585 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
586 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
587 OSTEOMYELITIS 1 0.0001
588 DRUG EFFECT INCOMPLETE 2 0.0001
589 PELVIC PAIN 1 0.0001
590 PRURITUS 21 0.0001
591 HAEMATOCHEZIA 3 0.0001
592 HYPERHIDROSIS 7 0.0001
593 HEADACHE 34 0.0001
594 MEDICATION ERROR 3 0.0001
595 BACTERIAL INFECTION 1 0.0001
596 INCREASED APPETITE 1 0.0001
597 BLOOD PRESSURE INCREASED 8 0.0001
598 DIZZINESS 26 0.0001
599 LOWER LIMB FRACTURE 1 0.0001
600 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
601 PALPITATIONS 6 0.0001
602 SKIN FISSURES 1 0.0001
603 SYNCOPE 5 0.0000
604 FEEDING DISORDER 1 0.0000
605 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
606 INFECTION 7 0.0000
607 HALLUCINATION, VISUAL 1 0.0000
608 RETCHING 1 0.0000
609 IMPAIRED WORK ABILITY 1 0.0000
610 IRRITABLE BOWEL SYNDROME 1 0.0000
611 FAECES DISCOLOURED 1 0.0000
612 SEPTIC SHOCK 2 0.0000
613 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
614 TOOTH DISORDER 1 0.0000
615 SEPSIS 5 0.0000
616 SNEEZING 1 0.0000
617 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
618 PANCREATITIS ACUTE 1 0.0000
619 PRODUCT AVAILABILITY ISSUE 1 0.0000
620 PYREXIA 15 0.0000
621 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
622 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
623 ANXIETY 12 0.0000
624 BLOOD PRESSURE FLUCTUATION 1 0.0000
625 VISUAL IMPAIRMENT 5 0.0000
626 DRY EYE 2 0.0000
627 PRODUCT COMPLAINT 1 0.0000
628 CARDIOVASCULAR DISORDER 1 0.0000
629 ACUTE KIDNEY INJURY 6 0.0000
630 UNRESPONSIVE TO STIMULI 1 0.0000
631 RASH GENERALISED 1 0.0000
632 DIPLOPIA 1 0.0000
633 HAEMORRHAGE 4 0.0000
634 MUCOSAL INFLAMMATION 1 0.0000
635 MUSCULOSKELETAL PAIN 2 0.0000
636 DERMATITIS ATOPIC 2 0.0000
637 DEPRESSED MOOD 2 0.0000
638 CHEST PAIN 7 0.0000
639 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
640 EAR INFECTION 1 0.0000
641 DRY SKIN 5 0.0000
642 MENSTRUATION IRREGULAR 1 0.0000
643 JAUNDICE 1 0.0000
644 FREQUENT BOWEL MOVEMENTS 1 0.0000
645 BLOOD BILIRUBIN INCREASED 1 0.0000
646 DRY MOUTH 3 0.0000
647 RASH PRURITIC 2 0.0000
648 RENAL IMPAIRMENT 3 0.0000
649 ANGINA PECTORIS 1 0.0000
650 HYPERSOMNIA 1 0.0000
651 SEIZURE 4 0.0000
652 PANCREATIC CARCINOMA 1 0.0000
653 PRODUCT STORAGE ERROR 3 0.0000
654 BONE PAIN 2 0.0000
655 URINARY INCONTINENCE 1 0.0000
656 WHEEZING 2 0.0000
657 IRRITABILITY 2 0.0000
658 PREMATURE BABY 1 0.0000
659 DRUG ADMINISTRATION ERROR 1 0.0000
660 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
661 LIMB DISCOMFORT 1 0.0000
662 HYPOTHYROIDISM 1 0.0000
663 MOVEMENT DISORDER 1 0.0000
664 NIGHT SWEATS 1 0.0000
665 DEPRESSION 7 0.0000
666 EYE DISORDER 1 0.0000
667 STAPHYLOCOCCAL INFECTION 1 0.0000
668 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
669 VIRAL INFECTION 1 0.0000
670 INSOMNIA 8 0.0000
671 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
672 FLUSHING 3 0.0000
673 CHEST DISCOMFORT 3 0.0000
674 SINUSITIS 3 0.0000
675 HEART RATE DECREASED 1 0.0000
676 INJURY 2 0.0000
677 CEREBRAL HAEMORRHAGE 1 0.0000
678 MOBILITY DECREASED 2 0.0000
679 PANIC ATTACK 1 0.0000
680 RESTLESSNESS 1 0.0000
681 DYSURIA 1 0.0000
682 DISORIENTATION 1 0.0000
683 MALAISE 11 0.0000
684 JOINT SWELLING 3 0.0000
685 BLINDNESS 1 0.0000
686 LOSS OF CONSCIOUSNESS 3 0.0000
687 HYPOACUSIS 1 0.0000
688 OVERDOSE 5 0.0000
689 BALANCE DISORDER 2 0.0000
690 VAGINAL HAEMORRHAGE 1 0.0000
691 MENTAL DISORDER 1 0.0000
692 INTENTIONAL PRODUCT MISUSE 2 0.0000
693 NAUSEA 18 0.0000
694 ANGIOEDEMA 1 0.0000
695 DEHYDRATION 3 0.0000
696 COLITIS ULCERATIVE 1 0.0000
697 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
698 GASTROINTESTINAL DISORDER 2 0.0000
699 THERAPY NON-RESPONDER 1 0.0000
700 NEPHROLITHIASIS 1 0.0000
701 CARDIAC DISORDER 2 0.0000
702 VOMITING 10 0.0000
703 DYSPNOEA 12 0.0000
704 PRODUCTIVE COUGH 1 0.0000
705 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
706 NERVOUSNESS 1 0.0000
707 DISTURBANCE IN ATTENTION 1 0.0000
708 ANAPHYLACTIC REACTION 1 0.0000
709 ARTHROPATHY 1 0.0000
710 OXYGEN SATURATION DECREASED 1 0.0000
711 HERPES ZOSTER 1 0.0000
712 PRODUCT SUBSTITUTION ISSUE 1 0.0000
713 SURGERY 1 0.0000
714 NASAL CONGESTION 1 0.0000
715 PAIN IN EXTREMITY 5 0.0000
716 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
717 STOMATITIS 1 0.0000
718 ILL-DEFINED DISORDER 1 0.0000
719 MUSCLE SPASMS 3 0.0000
720 EXPOSURE DURING PREGNANCY 1 0.0000
721 RHINORRHOEA 1 0.0000
722 DEEP VEIN THROMBOSIS 1 0.0000
723 BLOOD PRESSURE DECREASED 1 0.0000
724 PRODUCT QUALITY ISSUE 2 0.0000
725 ABDOMINAL PAIN UPPER 3 0.0000
726 MEMORY IMPAIRMENT 2 0.0000
727 SLEEP DISORDER 1 0.0000
728 BRONCHITIS 1 0.0000
729 EPISTAXIS 1 0.0000
730 ASTHENIA 5 0.0000
731 HOT FLUSH 1 0.0000
732 UNEVALUABLE EVENT 1 0.0000
733 PERIPHERAL SWELLING 2 0.0000
734 BACK PAIN 3 0.0000
735 DIARRHOEA 8 0.0000
736 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
737 MYALGIA 2 0.0000
738 URINARY TRACT INFECTION 2 0.0000
739 MYOCARDIAL INFARCTION 2 0.0000
740 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
741 COVID-19 2 0.0000
742 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
743 DEVICE ISSUE 1 0.0000
744 SUICIDAL IDEATION 1 0.0000
745 NASOPHARYNGITIS 2 0.0000
746 COUGH 3 0.0000
747 PRODUCT USE ISSUE 2 0.0000
748 PULMONARY EMBOLISM 1 0.0000
749 NEUROPATHY PERIPHERAL 1 0.0000
750 DRUG INTOLERANCE 1 0.0000
751 HEART RATE INCREASED 1 0.0000
752 ILLNESS 1 0.0000
753 CONSTIPATION 2 0.0000
754 RHEUMATOID ARTHRITIS 1 0.0000
755 FATIGUE 6 0.0000
756 RENAL FAILURE 1 0.0000
757 HOSPITALISATION 1 0.0000
758 CONFUSIONAL STATE 1 0.0000
759 TREMOR 1 0.0000
760 FALL 2 0.0000
761 TOXICITY TO VARIOUS AGENTS 1 0.0000
762 GAIT DISTURBANCE 1 0.0000
763 SOMNOLENCE 1 0.0000
764 ARTHRALGIA 2 0.0000
765 HYPERTENSION 1 0.0000
766 INCORRECT DOSE ADMINISTERED 1 0.0000
767 ABDOMINAL PAIN 1 0.0000
768 DEATH 1 0.0000